The Olive Lab is looking for a postdoc to lead our translational program on RAS inhibition in pancreatic cancer. Should have exceptional scientific and project management skills, and experience with transdisciplinary research. Must be a good human. olivelab.org

Nwosu Lab Cornell MBG has opened a call for postdoc applicants. Please kindly repost and or forward to potential applicants. Job posting: academicjobsonline.org/ajo/jobs/26453 Lab website: nwosulab.com

When everything is urgent, nothing is urgent.

Proud to have helped launch the Columbia Early Onset Colorectal Cancer Program Herbert Irving Comprehensive Cancer Center NYP with Beatrice Dionigi MD,FACS,FACRS and Yoanna Pumpalova. cancer.columbia.edu/early-onset-co…

Congratulations to CU-DLDRC Associate Director, Timothy Wang, MD, who is the new Vice Chair for Academic Programs for the Department of Medicine at the Vagelos College of Physicians and Surgeons! Dr Wang will add this new role to his portfolio effective September 3rd, 2024.

Hiring committees take note...

New online perspective article Cancer Research article timed with the ongoing #PancreaticCancer stroma session at #AACRPan24 Pancreatic Cancer-Associated Fibroblasts: Where do we go from here? A conversation with three experts on the PDAC stroma (Mara Sherman Lab Dr. Edna Cukierman, Ph.D. &

I am excited to see this story by my talented Master's Student, Kristina Høj. Her research dives into age-related decline in pancreas regeneration and how it’s linked to a proinflammatory response to injury. Gastro Hep Advances,@UCPH_BRIC, tinyurl.com/4e2uz2sb

We are thrilled to welcome Michel Sadelain, MD, PhD, a global pioneer in CAR-T therapies, to Columbia and the HICCC.

There is a new tool on BioIcons to turn any protein (in PDB format) into a 2D vector illustration in SVG format. You can upload any PDB file or import from PDB, AlphaFoldDB or ESMFoldDB. Feedback welcome :) bioicons.com/pdb2vector/

Revolution Medicines has launched its ph 3 study of RMC-6236 (RASolute 302) in patients with previously treated #PancreaticCancer. 1:1 randomization against physician’s choice of chemotherapy. A registration trial for KRAS inhibitor in pancreatic cancer! clinicaltrials.gov/study/NCT06625…

Really excited for my postdoc Marie Hasselluhn who received a 4th percentile score on her K99 application. Folks, she's on the job market!

On behalf of our Phase I program Herbert Irving Comprehensive Cancer Center , proud of Benjamin Herzberg presenting exciting initial data on IDE397 in MTAP-del tumors at the EORTC - National Cancer Institute - AACR conference ir.ideayabio.com/2024-10-25-IDE… We are excited to offer this study to our patients recruit.cumc.columbia.edu/studyinfopage/…

New post on our website with updated information on the clinical development of RAS inhibitors for pancreatic cancer. I'll summarize on twitter sooner, but here's the full version: olivelab.org/ras-inhibitor-…

ICYMI, the new issue of Cancer Research is online and features the print version of the In Focus commentary #PancreaticCancer–Associated Fibroblasts: Where Do We Go from Here? aacrjournals.org/cancerres/arti… By Eileen Carpenter, Débora Vendramini-Costa, Ph.D Marie Hasselluhn Mara Sherman Lab PascaLab

Suddenly seeing a huge number of fellow scientists show up on BlueSky. FYI I'm one of them. Come follow me: KenOliveLab.bsky.social

Sad to miss the first #PCAMChat24. Briefly, this is Ken Olive from Herbert Irving Comprehensive Cancer Center. I lead a translational research lab dedicated to #PDAC research. Excited to join in for part 2!